Skip to content

: Interferon Omega Antibody, Serum

Published: August 9, 2026Updated: August 16, 2026

: This test looks for antibodies in your blood that target interferon omega, a protein involved in immune signaling. It is most often used as an investigational marker in autoimmune conditions such as type 1 diabetes.

Quick summary

[": The test detects a specific immune protein (antibody) against interferon omega in a serum sample, but it does not by itself diagnose or rule out any disease."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
22405-5
Short code
L inter Pomon Ab Titr Ser
Synonyms
L inter Pomon Ab Titr Ser
Category
coagulation
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

: What Is Being Measured

: Interferon omega is a signaling protein that helps regulate immune responses. This test detects antibodies that bind to interferon omega in a sample of serum, the clear liquid part of blood. The presence of these antibodies is a research and specialty finding rather than a routine screening result.

: How the Sample Is Collected

: A healthcare professional collects a blood sample from a vein, usually in your arm, and the serum is separated in the laboratory for testing. No special preparation is typically required, but follow any instructions from your care team.

: What the Results Mean

: A positive result indicates that antibodies against interferon omega were detected, while a negative result indicates they were not. Because this is a specialized marker, results should always be interpreted together with your symptoms, other lab tests, and your medical history by a qualified clinician.

: Limits of the Test

: This test is not a stand-alone diagnostic tool. Detection of these antibodies may be associated with certain autoimmune or endocrine conditions, but it can also appear in other contexts, so it cannot confirm or exclude a diagnosis on its own.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

: Antibodies to interferon omega have been described mainly in research settings and in some patients with autoimmune endocrine conditions, particularly type 1 diabetes. The clinical significance depends heavily on the individual patient context, and the test is generally used to support, not replace, standard diagnostic evaluation.

Short name

: IFN-ω Antibody

Frequently asked questions

: Do I need to fast before this test?
: Fasting is usually not required for antibody testing, but follow any specific instructions given by your healthcare provider or laboratory.
: Can a positive result mean I have diabetes?
: Not necessarily. A positive result is not a diagnosis. It must be interpreted alongside your symptoms, blood sugar tests, and other clinical information by your doctor.
: Is this a routine test?
: No. This is a specialized or investigational marker and is not part of standard routine screening; it is typically ordered in specific clinical or research settings.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy